Literature DB >> 2548276

Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.

A Z Kapikian1, J Flores, Y Hoshino, K Midthun, M Gorziglia, K Y Green, R M Chanock, L Potash, S D Sears, M L Clements.   

Abstract

Major advances have been made in elucidating the etiologic agents of severe infantile diarrhea, and it is clear that rotaviruses are the single most important etiologic agents. Progress in the development of rotavirus vaccine candidates has also moved swiftly with the "Jennerian" approach, in which a related live, attenuated rotavirus strain from a nonhuman host is used as the immunizing antigen. If this strategy is not effective against all rotavirus serotypes, reassortant rotaviruses hold great promise for the development of a multivalent vaccine. Field trials with the "Jennerian" approach vaccines are under way, and phase 1 trials with the reassortants have been initiated.

Entities:  

Keywords:  Biology; Child Mortality; Clinical Research; Demographic Factors; Developing Countries; Diarrhea; Diarrhea, Infantile--etiology; Diseases; Epidemics; Gastrointestinal Effects; Infant Mortality; Morbidity; Mortality; Physiology; Population; Population Dynamics; Research Methodology; Vaccines; Viral Diseases--etiology

Mesh:

Substances:

Year:  1989        PMID: 2548276     DOI: 10.1093/clinids/11.supplement_3.s539

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  4 in total

1.  Serotype variation of group A rotaviruses over nine winter epidemics in southeastern New England.

Authors:  R E Begue; P H Dennehy; J Huang; P Martin
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

2.  Antibodies to seven rotavirus serotypes in cord sera, maternal sera, and colostrum of German women.

Authors:  H Brüssow; J Sidoti; L Lerner; H Rahim; W Eckstein; H Werchau; C Mietens
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

3.  Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence.

Authors:  R L Broome; P T Vo; R L Ward; H F Clark; H B Greenberg
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

Review 4.  Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality.

Authors:  Tintu Varghese; Gagandeep Kang; Andrew Duncan Steele
Journal:  Vaccines (Basel)       Date:  2022-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.